BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6084612)

  • 1. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.
    Lafon M; Ideler J; Wunner WH
    Dev Biol Stand; 1984; 57():219-25. PubMed ID: 6084612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
    Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
    J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
    Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M
    Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic variants of the rabies virus. Selection with antiglycoprotein monoclonal antibodies].
    Coulon P; Rollin P; Aubert M; Flamand A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):105-13. PubMed ID: 7181560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Avirulent mutants of the rabies virus: change in site III of the glycoprotein].
    Diallo A
    Ann Rech Vet; 1986; 17(1):3-6. PubMed ID: 2430498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
    Sloan SE; Hanlon C; Weldon W; Niezgoda M; Blanton J; Self J; Rowley KJ; Mandell RB; Babcock GJ; Thomas WD; Rupprecht CE; Ambrosino DM
    Vaccine; 2007 Apr; 25(15):2800-10. PubMed ID: 17240489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the antigenic structure of the E1 glycoprotein of the Venezuelan equine encephalomyelitis virus using monoclonal antibodies].
    Razumov IA; Agapov EV; Pereboev AV; Protopopova EV; Lebedeva SD; Loktev VB
    Mol Gen Mikrobiol Virusol; 1991 Jun; (6):21-4. PubMed ID: 1719387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies.
    Lafon M; Wiktor TJ; Macfarlan RI
    J Gen Virol; 1983 Apr; 64 (Pt 4)():843-51. PubMed ID: 6834008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H; Coulon P; Lafay F; Flamand A
    Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence.
    Prehaud C; Coulon P; LaFay F; Thiers C; Flamand A
    J Virol; 1988 Jan; 62(1):1-7. PubMed ID: 2446011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.
    Flamand A; Wiktor TJ; Koprowski H
    J Gen Virol; 1980 May; 48(1):105-9. PubMed ID: 6155432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reactions of monoclonal antibodies with structural proteins of mumps virus.
    Orvell C
    J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.
    Dietzschold B; Wunner WH; Wiktor TJ; Lopes AD; Lafon M; Smith CL; Koprowski H
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):70-4. PubMed ID: 6185960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic sites on the ERA rabies virus nucleoprotein and non-structural protein.
    Lafon M; Wiktor TJ
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2125-33. PubMed ID: 2413164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
    Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
    Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic spectrum of wild strains and vaccinal strains of rabies virus in Senegal defined by antinucleocapsid monoclonal antibodies].
    Digoutte JP
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):99-103. PubMed ID: 7181573
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of rabies virus neutralization.
    Flamand A; Raux H; Gaudin Y; Ruigrok RW
    Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies as a tool for rabies epidemiological studies.
    Rollin PE; Sureau P
    Dev Biol Stand; 1984; 57():193-7. PubMed ID: 6084611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.